| Date Filed | Type | Description |
| 07/10/2023 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 1,880 shares
@ $2.8, valued at
$5.3k
|
|
| 06/09/2023 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 2,791 shares
@ $17.0368, valued at
$47.5k
Sold 6,106 shares
@ $17.0379, valued at
$104k
|
|
| 03/23/2023 |
4/A
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 19,489 shares
@ $20.1973, valued at
$393.6k
|
|
| 03/10/2023 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 24,672 shares
@ $21.1559, valued at
$522k
Granted 23,120 shares
@ $0
Granted 37,229 shares
@ $0
Sold 12,103 shares
@ $20.1973, valued at
$244.4k
Sold 19,486 shares
@ $20.1973, valued at
$393.6k
|
|
| 02/23/2023 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 85,300 shares
@ $0
Granted 143,100 options to buy
@ $22.6, valued at
$3.2M
|
|
| 01/10/2023 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 1,538 shares
@ $19.95, valued at
$30.7k
|
|
| 12/09/2022 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 2,543 shares
@ $15.79, valued at
$40.2k
|
|
| 10/11/2022 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 1,296 shares
@ $14.26, valued at
$18.5k
|
|
| 09/08/2022 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 1,772 shares
@ $12.26, valued at
$21.7k
|
|
| 07/08/2022 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 1,296 shares
@ $12.4, valued at
$16.1k
|
|
| 06/08/2022 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 1,772 shares
@ $9.5, valued at
$16.8k
|
|
| 04/08/2022 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 1,311 shares
@ $12.73, valued at
$16.7k
|
|
| 03/09/2022 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 7,081 shares
@ $12.69, valued at
$89.9k
|
|
| 02/16/2022 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 179,400 shares
@ $0
Granted 298,000 options to buy
@ $15.6, valued at
$4.6M
|
|
| 01/07/2022 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 1,536 shares
@ $13.93, valued at
$21.4k
|
|
| 10/08/2021 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 1,859 shares
@ $10.2, valued at
$19k
|
|
| 07/08/2021 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 1,859 shares
@ $25.06, valued at
$46.6k
|
|
| 02/26/2021 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 82,000 shares
@ $0
Granted 164,000 options to buy
@ $53.01, valued at
$8.7M
|
|
| 01/08/2021 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 5,411 shares
@ $38.31, valued at
$207.3k
|
|
| 06/12/2020 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Bought 8,000 shares
@ $36.2853, valued at
$290.3k
Bought 19,800 shares
@ $35.2828, valued at
$698.6k
|
|
| 01/08/2020 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 60,000 shares
@ $0
Granted 300,000 options to buy
@ $43.35, valued at
$13M
|
|
| 01/08/2020 |
3
| Conterno Enrique A (CEO) has filed a Form 3 on FIBROGEN INC |
| 02/20/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2018 |
4
| Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) has filed a Form 4 on LILLY ELI & CO|
Txns:
| Sold 25,000 shares
@ $85, valued at
$2.1M
|
|
| 05/03/2018 |
4
| Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) has filed a Form 4 on LILLY ELI & CO|
Txns:
| Paid exercise price by delivering 8,934 shares
@ $81.07, valued at
$724.3k
Exercised 20,000 restricted stock units
@ $0 |
|
| 02/05/2018 |
4
| Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) has filed a Form 4 on LILLY ELI & CO|
Txns:
| Paid exercise price by delivering 9,512 shares
@ $81.45, valued at
$774.8k
Exercised 21,326 restricted stock units
@ $0 |
|
| 01/31/2018 |
4
| Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) has filed a Form 4 on LILLY ELI & CO|
Txns:
| Granted 12,437 shares
@ $87.6, valued at
$1.1M
Granted 12,222 restricted stock units
@ $0 |
|
| 12/13/2017 |
4
| Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) has filed a Form 4 on LILLY ELI & CO|
Txns:
| Granted 34,615 restricted stock units
@ $0 |
|
| 05/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|